SERPINE2/PN-1 regulates the DNA damage response and radioresistance by activating ATM in lung cancer
Autor: | Shirong Zhang, Qiong Wu, Yasi Xu, Linglan Tu, Lucheng Zhu, Shu-jun Xie, Shenglin Ma, Yan-yan Zhao, Jingjing Zhang, Xueqin Chen, Kan Wu, Yuhong Yang, Yuqing Wang |
---|---|
Rok vydání: | 2022 |
Předmět: |
Cancer Research
Lung Neoplasms Cell cycle checkpoint DNA Repair Cell Survival DNA damage DNA repair RAD51 Ataxia Telangiectasia Mutated Proteins Biology Radiation Tolerance Cell Movement Cell Line Tumor Radiation Ionizing Radioresistance Serpin E2 medicine Humans Neoplasm Invasiveness Radiosensitivity Phosphorylation Lung cancer Cell Proliferation MRE11 Homologue Protein medicine.disease Oncology Cancer research Rad51 Recombinase Homologous recombination DNA Damage |
Zdroj: | Cancer Letters. 524:268-283 |
ISSN: | 0304-3835 |
DOI: | 10.1016/j.canlet.2021.10.001 |
Popis: | Although the DNA damage response (DDR) is associated with the radioresistance characteristics of lung cancer cells, the specific regulators and underlying mechanisms of the DDR are unclear. Here, we identified the serine proteinase inhibitor clade E member 2 (SERPINE2) as a modulator of radiosensitivity and the DDR in lung cancer. Cells exhibiting radioresistance after ionizing radiation show upregulation of SERPINE2, and SERPINE2 knockdown improves tumor radiosensitivity in vitro and in vivo. Functionally, SERPINE2 deficiency causes a reduction in homologous recombination repair, rapid recovery of cell cycle checkpoints, and suppression of migration and invasion. Mechanistically, SERPINE2 knockdown inhibits the accumulation of p-ATM and the downstream repair protein RAD51 during DNA repair, and RAD51 can restore DNA damage and radioresistance phenotypes in lung cancer cells. Furthermore, SERPINE2 can directly interact with MRE11 and ATM to facilitate its phosphorylation in HR-mediated DSB repair. In addition, high SERPINE2 expression correlates with dismal prognosis in lung adenocarcinoma patients, and a high serum SERPINE2 concentration predicts a poor response to radiotherapy in non-small cell lung cancer patients. In summary, these findings indicate a novel regulatory mechanism by which SERPINE2 modulates the DDR and radioresistance in lung cancer. |
Databáze: | OpenAIRE |
Externí odkaz: |